MiMedx Group, Inc.
MDXG
$6.68
$0.050.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.00% | 2.87% | 7.32% | 18.18% | 16.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.00% | 2.87% | 7.32% | 18.18% | 16.75% |
| Cost of Revenue | 22.16% | 3.60% | 9.36% | 4.57% | -3.67% |
| Gross Profit | 4.12% | 2.71% | 6.91% | 21.04% | 21.64% |
| SG&A Expenses | 11.32% | 3.11% | -13.73% | -0.86% | 3.07% |
| Depreciation & Amortization | 0.52% | 1.05% | -0.52% | -0.53% | 5.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.60% | 2.85% | -9.46% | -0.78% | 13.13% |
| Operating Income | -28.03% | 3.02% | 116.35% | 3,997.65% | 36.95% |
| Income Before Tax | -19.15% | 21.05% | 152.98% | 703.33% | 41.13% |
| Income Tax Expenses | 110.20% | 499.15% | 7,660.81% | 4,503.92% | -133,582.14% |
| Earnings from Continuing Operations | -85.50% | -10.90% | 90.48% | 566.58% | 421.75% |
| Earnings from Discontinued Operations | -100.00% | 170.45% | 100.05% | 106.58% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -86.09% | -5.14% | 1,368.75% | 285.85% | 13,017.15% |
| EBIT | -28.03% | 3.02% | 116.35% | 3,997.65% | 36.95% |
| EBITDA | -13.23% | 5.41% | 110.17% | 2,292.66% | 33.33% |
| EPS Basic | -87.15% | -5.16% | 2,700.00% | 208.58% | 2,288.33% |
| Normalized Basic EPS | -33.79% | -1.78% | 98.99% | 574.76% | 32.36% |
| EPS Diluted | -86.13% | -9.65% | 1,358.54% | 205.15% | 1,844.93% |
| Normalized Diluted EPS | -19.08% | 25.38% | 149.10% | 564.08% | 6.73% |
| Average Basic Shares Outstanding | 23.16% | 26.36% | 27.15% | 27.98% | 5.72% |
| Average Diluted Shares Outstanding | 0.79% | -0.93% | 1.39% | 31.14% | 31.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |